EC
Therapeutic Areas
Scilex Holding Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ZTlido® (lidocaine topical system) 1.8% | Post-Herpetic Neuralgia (PHN) | Commercial |
| Elyxyb® (celecoxib oral solution) | Acute Migraine | Commercial |
| Gloperba® (colchicine oral solution) | Prophylaxis of Gout Flares | Commercial |
| SP-102 (SEMDEXA™) | Lumbosacral Radicular Pain (Sciatica) | Phase 3 |
| SP-103 (lidocaine topical system) 5.4% | Acute Lower Back Pain; Chronic Neck Pain | Phase 2 / Phase 2/3 |
| SP-104 (low-dose naltrexone DR capsules) | Fibromyalgia | Preclinical |
| KDS2010 | Undisclosed (Neurological/Pain) | Not Disclosed |